Martin Šmakal

1961 -

languages spoken, written or signed: Czech

occupation: researcher, internist, oncologist, physician

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 11

Date

Title

Authors

2017-10-23

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.

Luc Y Dirix, Martin Šmakal, Marc E Lippman
2014-10-15

Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial

Martin Šmakal, Josep Tabernero Caturla
2014-04-08

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.

Josep Tabernero Caturla, David Cunningham, Salvatore Siena, György Bodoky, Jacek Jassem, Martin Šmakal
2013-09-01

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Salvatore Siena, Josep Tabernero Caturla, György Bodoky, David Cunningham, Martin Šmakal, Jacek Jassem
2013-10-24

Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practice

Martin Šmakal, Matthias Schwenkglenks
2011-02-07

Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer

Charles Rudin, Martin Šmakal
2010-10-04

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

Salvatore Siena, Josep Tabernero Caturla, György Bodoky, David Cunningham, Martin Šmakal, Jacek Jassem
2008-06-01

Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer

Jack W. Singer, Martin Šmakal, Sergey Orlov
2008-01-28

Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study

Martin Šmakal, Heinz Ludwig
2004-10-01

Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer

Martin Šmakal, David Cunningham, Timothy Iveson
1999-10-01

Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis

Martin Šmakal

Human - wd:Q57963303

Welcome to Inventaire

the library of your friends and communities

learn more